Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda crawled date : 2022 - 03 - 28 save search
Novo Nordisk receives FDA approval of higher-dose Ozempic® 2 mg providing increased glycemic control for adults with type 2 diabetes
Published: 2022-03-28 (Crawled : 23:00) - prnewswire.com
NVO | $122.75 -1.43% 0.67% 42K
|
Health Technology
|
| O: 2.86%
H: 0.47%
C: -0.72%
ozempic fda control approval diabetes
CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath
Published: 2022-03-28 (Crawled : 17:00) - biospace.com/
CRMD | $5.58 2.95% 170K
|
Health Technology
|
| O: 1.16%
H: 4.24%
C: -7.67%
fda application resubmission drug
Therapeutic Solutions International Selects Premier Regenerative Medicine CRO Biorasi to Initiate and Run Phase III FDA Registration Clinical Trial for JadiCell™ Universal Donor Adult Stem Cell Product
Published: 2022-03-28 (Crawled : 17:00) - biospace.com/
TSOI | $0.0007 33M
|
Manufacturing
|
| O: 5.63%
H: 16.39%
C: 5.74%
fda trial solutions international
Amylyx Pharmaceuticals Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on AMX0035
Published: 2022-03-28 (Crawled : 17:00) - biospace.com/
AMLX | $1.98 -1.0% -1.52% 6K
|
|
| O: -3.56%
H: 6.51%
C: -33.6%
amx0035 fda sodium phenylbutyrate sclerosis als taurursodiol
FDA Authorized Reduced-Nicotine Cigarette from 22nd Century Group (Nasdaq: XXII) That ‘Helps You Smoke Less’ Obtains Illinois Tobacco Product Listing
Published: 2022-03-28 (Crawled : 14:00) - globenewswire.com
XXII 4 | $1.67 -2.34% 76K
|
Health Technology
|
| O: 1.24%
H: 5.74%
C: -3.28%
fda authorized group
Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease
Published: 2022-03-28 (Crawled : 13:00) - globenewswire.com
PRTA 4 | $20.57 -2.05% -1.94% 0
|
Health Technology
|
| O: 0.38%
H: 2.41%
C: -0.35%
prx012 treatment fda clearance disease antibody alzheimer alzheimer’s alzheimer's disease alzheimer's anti-amyloid beta
Stealth BioTherapeutics Receives Orphan Drug Designation from FDA for Elamipretide for the Treatment of Friedreich's Ataxia
Published: 2022-03-28 (Crawled : 12:20) - biospace.com/
MITO | $0.32 0.25%
|
Health Technology
|
| O: 2.92%
H: 2.95%
C: -3.91%
treatment fda drug elamipretide friedreich's ataxia designation friedreich’s ataxia
STAAR Surgical Announces U.S. FDA Approval of EVO Visian® Implantable Collamer® Lenses
Published: 2022-03-28 (Crawled : 11:00) - biospace.com/
STAA | $46.77 0.93% 0.96% 0
|
Health Technology
|
| O: 14.98%
H: 3.86%
C: -3.78%
visian fda approval
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
AGBA | News | $1.4 250.0% 35M
|
Finance
ZCMD | $2.18 50.35% 24M
|
Commercial Services
RWOD | $12.0 50.06% 3.9M
|
n/a
AULT | $0.3174 31.1% 28M
|
Manufacturing
WISA 4 | $7.11 20.71% 4.7M
|
Electronic Technology
INDO | $4.9 20.1% 2.2M
|
Energy Minerals
NURO | $4.32 18.36% 66K
|
Health Technology
HUBC | $1.52 17.83% 4.7M
|
n/a
MCB 4 | $38.545 16.45% 34K
|
Finance
BHAT | $1.06 11.58% 9.3K
|
Consumer Durables
Your saved searches
Save your searches and get alerts when important news are released.